The link between nuchal translucency and congenital heart disease

1. Nicolaides K.H., Azar G., Byrne D., Mansur C. & Marks K. (1992). Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ. 304, 867 - 86910.1136/bmj.304.6831.867Search in Google Scholar

2. Pajkrt E., Bilardo C.M., van Lith J.M.M., Mol B.W.J. & Bleker O.P. (1995). Nuchal translucency measurement in normal fetuses. Obstet Gynecol. 86, 994 - 99710.1016/0029-7844(95)00310-NSearch in Google Scholar

3. Pandya P.P., Snijders R.J.M., De Johnson S.P., Luordes N.M. & Nicolaides K.H. (1995). Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10-11 weeks of gestation. Br J Obstet Gynaecol. 102, 957 - 96210.1111/j.1471-0528.1995.tb10902.xSearch in Google Scholar

4. Bilardo CM , Muller MA , Pajkrt E , Clur SA , van Zalen MM , Bijlsma EK . 2007 . Increased nuchal translucency and normal Karyotype : time for prenatal reassurance . Ultrasound Obstet Gynecol 30 : 11 - 18 .10.1002/uog.4044Search in Google Scholar

5. Souka A.P., Von Kaisenberg C.S., Hyett J.A., Snoek J.D. & Nicolaides K.H. (2005). Increased nuchal translucency with normal karyotype. Am J Obstet Gynecol. 192, 1005 - 102110.1016/j.ajog.2004.12.093Search in Google Scholar

6. Westin M., Saaltvedt S., Bergman G., Almstrom H., Grunewald C. & Valentin L. (2007) . By how much does increased nuchal transluncency increased the risk of adverse outcome in chromosomally normal fetuses? A study of 16Is measurement of nuchal translucency thickness a useful screening tool for heart defects? A study of 16260 fetuses derived from an unselected pregnant population. Ultrasound Obstet Gynecol. 29, 150 - 15810.1002/uog.3905Search in Google Scholar

7. Hyett J., Perdu M., Sharland G.K., Snijders R. & Nicolaides K.H. (1999). Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study. BMJ. 318, 81 - 8510.1136/bmj.318.7176.81Search in Google Scholar

8. Makrydimas G., Sotiriadis A. & Ioannidis J.P. (2003). Screening performance of first - trimester nuchal translucency for major cardiac defects: a meta-analysis. Am J Obstet Gynecol. 189, 1330 - 133510.1067/S0002-9378(03)00645-8Search in Google Scholar

9. Simpson L.L., Malone F.D., Saade G.R. & D’Alton M.E. (2007). Nuchal translucency and the risk of congenital heart disease . Obstet Gynecol. 109, 1456 - 1457Search in Google Scholar

10. Hyett J., Snoek J. & Nicolaides K.H. (2007). Nuchal translucency and the risk of congenital heart disease. (Letter to editor). Obstet Gynecol. 109, 1455 - 145610.1097/01.AOG.0000267265.89831.c017540825Search in Google Scholar

11. Ghi T., Huggon I.C., Zosmer N. & Nicolaides K.H. (2001). Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype. Ultrasoung Obstet Gynecol. 18, 610 - 61410.1046/j.0960-7692.2001.00584.x11844199Search in Google Scholar

12. Makrydimas G., Sotiriadis A. & Huggon I.C. et al. (2005). Nuchal translucency and fetal cardiac defects: a pooled analysis of major fetal echocardiography centers. Am J Obstet Gynecol. 192, 89 - 9510.1016/j.ajog.2004.06.081Search in Google Scholar

13. Hyett J. (2004). Does nuchal translucency have a role in fetal cardiac screening? Prenat Diagn. 24, 1130 - 1135Search in Google Scholar

14. Galindo A., Comas C. & Martinez J.M. et al. (2003). Cardiac defects in chromosomally normal fetuses with increased nuchal translucency at 10 - 14 weeks gestation. J Matern Fetal Neonatal Med. 13, 163 - 170Search in Google Scholar

15. Clur S.A., Mathijssen I.B. & Pajkrt E. et al. (2008). Structural heart defects associated with an increased nuchal translucency: 9 years’ experience in a referral center. Prenat Diagn. 28, 347 - 35410.1002/pd.1985Search in Google Scholar

16. Moll B.W.J. (1999). Down’s syndrome, cardiac anomalies and nuchal translucency. Fetal heart failure might link nuchal translucency and Down’s syndrome. BMJ. 318(7176), 70-7110.1136/bmj.318.7176.70Search in Google Scholar

17. Hyett J., Brizot M.L., von Kaisenberg C.S., McKie A.T., Farzaneh F. & Nicolaides K.H. (1996). Cardiac gene expression of atrial natriuretic peptide and brain natriuretic peptide in trisomic fetuses. Obstet Gynecol. 87, 506 -51010.1016/0029-7844(95)00486-6Search in Google Scholar

18. Nicolaides K.H., Heath V. & Cicero S. (2002). Increased fetal nuchal translucency at 11-14 weeks. Prenat Diagn. 22, 308 - 31510.1002/pd.30811981911Search in Google Scholar

19. Matias A., Huggon I., Areias J.C., Montenegro N. & Nicolaides K.H. (1999). Cardiac defects in chromosomally normal fetuses with abnormal ductus venosus blood flow at 10-14 weeks. Ultrasound Obstet Gynecol. 14, 307 - 31010.1046/j.1469-0705.1999.14050307.x10623988Search in Google Scholar

20. Allan L.D. (2006). The mystery of nuchal translucency. The Mannheimer Lecture. Cardiol Young. 16, 11 - 1710.1017/S104795110500203916454872Search in Google Scholar

21. Leiva M.C., Tolosa J.E. & Binotto C.N. et al. (1999). Fetal cardiac development and haemodynamics in the first trimester. Ultrasound Obstet Gynecol. 14, 167 - 17410.1046/j.1469-0705.1999.14030169.x10550875Search in Google Scholar

22. Haak M.C., Twisk J.W., Bertelings M.M., Gittenberger de Groot A.C. & van Vugt J.M. (2005). First trimester fetuses with increased nuchal translucency do not show altered intracardiac flow velocities. Ultrasound Obstet Gynecol. 25, 246 - 25210.1002/uog.181015719441Search in Google Scholar

23. Sedmera D., Cook A.C., Shirali G. & McQuinn T.C. (2005). Current issues and perspectives in hypoplasia of the left heart. Cardiol Young. 15, 56 - 7210.1017/S104795110500013215831164Search in Google Scholar

24. Oh C., Harmam C. & Baschat A.A. (2007). Abnormal first trimester ductus venosus blood flow: a risk for adverse outcome in fetuses with normal nuchal translucency. Ultrasound Obstet Gynecol. 30, 192 - 196Search in Google Scholar

25. Huisman T.W.A. & Bilardo C. (1997). Transient increase in nuchal translucency thickness and reverse end - diastolic ductus venosus flow in a fetus with trisomy 18. Ultrasound Obstet Gynecol. 10, 397 - 39910.1046/j.1469-0705.1997.10060397.x9476323Search in Google Scholar

26. Matias A., Gomes C., Flack N., Montenegro N. & Nicolaides K.H. (1998). Screening for chromosomal abnormalities at 10 - 14 weeks: the role of the ductus venous blood flow. Ultrasound Obstet Gynecol 12, 380 - 38410.1046/j.1469-0705.1998.12060380.x9918085Search in Google Scholar

27. Maiz N., Plasencia W., Dagklis T., Faros E. & Nicolaides K.H. (2008). Ductus venosus Doppler in fetuses with cardiac defects and high nuchal translucency thickness. Ultrasound Obstet Gynecol. 31, 256 - 26010.1002/uog.526218307193Search in Google Scholar

28. Simpson J.M. & Sharland G.K. (2000). Nuchal translucency and congenital heart defects: heart failure or not? Ultrasound Obstet Gynecol 16, 30 - 3610.1046/j.1469-0705.2000.00158.x11084962Search in Google Scholar

29. Huggon I.C., Turan O. & Allan L.D. (2004). Doppler assessment of cardiac function at 11-14 weeks’ gestation in fetuses with normal and increased nuchal translucency. Ultrasound Obstet Gynecol. 24, 390 - 39810.1002/uog.172015343592Search in Google Scholar

30. Faiola S., Tsoi E., Huggon I.C., Allan L.D. & Nicolaides K.H. (2005). Likelihood ratio for trisomy 21 in fetus with tricuspid regurgitation at 11 to 13 + 6 weeks scan. Ultrasound Obstet Gynecol. 26, 22 - 2710.1002/uog.192215937972Search in Google Scholar

31. Huggon I.C., DeFigueiredo D.B. & Allan L.D. (2003). Tricuspid regurgitation in the diagnosis of chromosomal anomalies in the fetus at 11 - 14 weeks of gestation. Heart. 89, 1071 - 107310.1136/heart.89.9.1071176786512923032Search in Google Scholar

32. Rudolph A.M. (2001). Congenital Diseases of the Heart (2nd ed). (pp. 3-44). New York: Futura Publishing CompanySearch in Google Scholar

33. Coceani F., Adeagbo A.S., Cutz E. & Olley P.M. (1984). Autonomic mechanism in the ductus venosus of the lamb. Am J Physiol. 247, H17 - H2410.1152/ajpheart.1984.247.1.H176742210Search in Google Scholar

34. Carmeliet P. (2003). Blood vessels and nerves: common signals, pathways and diseases. Nat Rev Genet. 4, 710 - 72010.1038/nrg115812951572Search in Google Scholar

35. Kirby M.L. (1991). Neural crest and the morphogenesis of the Down syndrome with special emphasis on cardiovascular development. Prog Clin Biol Res. 373, 215 - 225Search in Google Scholar

36. Yagel S., Cohen S.M. & Messing B. (2007). First trimester fetal heartscreening. Curr Opin Gynecol. 19, 183 - 19010.1097/GCO.0b013e3280895de617353687Search in Google Scholar

37. Carvalho J.S. (2004). Fetal heart scanning in the first trimester. Prenat Diagn. 24, 1060 - 106710.1002/pd.106315614834Search in Google Scholar

38. Lee W., Allan L. & Carvalho J.S. et al. (2008). ISUOG consensus statement: what constitutes a fetal echocardiogram? Ultrasound Obstet Gynecol. 32, 239 - 242Search in Google Scholar

39. Johnson B. & Simpson L.L. (2007). Screening for congenital heart disease: A move toward earlier echochardiography. Am J Perinatol. 24, 449 - 45610.1055/s-2007-98668117992711Search in Google Scholar

40. Bronshtein M., Zimmer E.Z. & Blazer S. (2008). The utility of detailed first trimester ultrasound examination in abnormal fetal nuchal translucency. Prenat Diagn. 28, 1037 - 1041 10.1002/pd.211918925580Search in Google Scholar